(Q43846327)

English

Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

quality of life

1 reference

based on heuristic

inferred from title

author name string

M Jerkeman

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Kaasa

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Hjermstad

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Kvaløy

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E Cavallin-Stahl

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

85-94

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.1385/mo:18:1:85

0 references

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11778974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/MO:18:1:85

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43846327&oldid=2103837802"